Gene therapy successful in trial treatment of hemophilia

• E-mail

E-mail this article
To:
Invalid E-mail address
Add a personal message:(80 character limit) Your E-mail:
Invalid E-mail address

Sending your article
Your article has been sent.

NEW YORK - Medical researchers in Britain have successfully treated six patients suffering from the blood-clotting disease known as hemophilia B by injecting them with the correct form of a defective gene, a landmark achievement in the troubled field of gene therapy. Hemophilia B, which was carried by Queen Victoria and affected most of the royal houses of Europe, is the first well-known disease to appear treatable by gene therapy, a technique with a 20-year record of almost unbroken failure.

To continue, please sign up or log in to BostonGlobe.com

Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com

Sign up

Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.

Sign up

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription.

Start here

BostonGlobe.com subscriber

Click to continue reading this article or to log in to BostonGlobe.com.

• Single Page
• 1
• 2
•  
•  

• E-mail

E-mail this article
To:
Invalid E-mail address
Add a personal message:(80 character limit) Your E-mail:
Invalid E-mail address

Sending your article
Your article has been sent.